Literature DB >> 7964993

Medulloblastoma in late adults: report of two cases and critical review of the literature.

L Cervoni1, A Maleci, M Salvati, R Delfini, G Cantore.   

Abstract

The authors describe two cases of medulloblastoma occurring in two men aged 71 and 67 years respectively. Medulloblastoma in late adults (older than 65 years) is an exceptional occurrence, and in this age group is generally of the classic type. Our first case was exceptional for the long survival of the patient compared with those so far reported for the same age group.

Entities:  

Mesh:

Year:  1994        PMID: 7964993

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

1.  MEDULLOBLASTOMA IN ADULTS. CLINICAL OBSERVATIONS ON A SERIES OF 29 CASES.

Authors:  G BORGHI; R CHIORINO
Journal:  Neurochirurgia (Stuttg)       Date:  1964-02

2.  [Medulloblastoma of the posterior cranial fossa in adults].

Authors:  V S ALEKSEEVA
Journal:  Vopr Neirokhir       Date:  1959 Nov-Dec

3.  Neonatal cerebellar medulloblastoma originating from the fetal external granular layer.

Authors:  M E Kadin; L J Rubinstein; J S Nelson
Journal:  J Neuropathol Exp Neurol       Date:  1970-10       Impact factor: 3.685

4.  The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases.

Authors:  H J Bloom; E N Wallace; J M Henk
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-01

Review 5.  Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.

Authors:  L J Rubinstein
Journal:  J Neurosurg       Date:  1985-06       Impact factor: 5.115

6.  Late recurrence of primitive neuroectodermal tumor/medulloblastoma.

Authors:  I B Lefkowitz; R J Packer; S G Ryan; N Shah; J Alavi; L B Rorke; L N Sutton; L Schut
Journal:  Cancer       Date:  1988-08-15       Impact factor: 6.860

7.  Cerebellar medulloblastoma in adults.

Authors:  P G Hughes
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

8.  Treatment of medulloblastoma in children: long-term results following surgery, radiotherapy and chemotherapy.

Authors:  C Mazza; A Pasqualin; R Da Pian; E Donati
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

9.  Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.

Authors:  G Kopelson; R M Linggood; G M Kleinman
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

10.  Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.

Authors:  E N Hughes; J Shillito; S E Sallan; J S Loeffler; J R Cassady; N J Tarbell
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

View more
  5 in total

1.  Arsonoliposomes for the potential treatment of medulloblastoma.

Authors:  Marco E Favretto; Showan Marouf; Panagiotis Ioannou; Sophia G Antimisiaris; Terence L Parker; Paraskevi Kallinteri
Journal:  Pharm Res       Date:  2009-07-22       Impact factor: 4.200

2.  An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth.

Authors:  Fadila Guessous; Ying Zhang; Charles diPierro; Lukasz Marcinkiewicz; Jann Sarkaria; David Schiff; Sean Buchanan; Roger Abounader
Journal:  Anticancer Agents Med Chem       Date:  2010-01       Impact factor: 2.505

Review 3.  Medulloblastoma: from molecular pathology to therapy.

Authors:  Alessandra Rossi; Valentina Caracciolo; Giuseppe Russo; Krzysztof Reiss; Antonio Giordano
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

4.  Cerebellar Medulloblastoma in Middle-to-Late Adulthood.

Authors:  Majid Aljoghaiman; Mahmoud S Taha; Marwah M Abdulkader
Journal:  Case Rep Pathol       Date:  2018-01-31

Review 5.  Role of Circular RNA in Brain Tumor Development.

Authors:  Swalih P Ahmed; Javier S Castresana; Mehdi H Shahi
Journal:  Cells       Date:  2022-07-06       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.